Editor's note: "US Stock Gold Mining" Keep up with daily market trends, insight, and consolidate hot and outstanding stocks, providing multi-dimensional investment opportunities for Mooer and helping them grasp investment opportunities with one chart! Focus on: 1. Performance and stock prices take off! Global fast fashion giant $Gap Inc (GPS.US)$ soared nearly 29% after its performance, reaching a new high for the year. Gap announced its first fiscal 2023 first-quarter results, with net sales of $3.4 billion, exceeding analysts' expectations of $3.28 billion, and earnings per share of $0.41, with overall comparable sales growth of 3%, better than expected 0.91%. In addition, the gross profit margin for the quarter reached 41.2%, higher than analysts' forecast of 38.5%. Its subsidiary brand Old Navy's same-store sales grew by 3%, exceeding market expectations of 2.5%. Based on this, Gap raised its sales and operating profit outlook for the year. Baird has recently raised its target share price for Gap from $23 to $28, and Goldman Sachs has raised its target share price for Gap from $20 to $27. 2. US electric power stocks collectively agitated! The largest wind and solar power generator developer in the United States $NextEra Energy (NEE.US)$, the fourth largest power plant in the United States $Southern Company (SO.US)$, the power and natural gas company $CenterPoint Energy (CNP.US)$, and the electrical production and transmission company $Edison International (EIX.US)$ have all reached new highs for the year. On the news front, as AI technology often requires a lot of energy to develop and operate, utility stocks are becoming a new opportunity for investors. 3. Low-key AI beneficiaries! Data storage giantToday's weather is good Today's weather is good.Please use your Futubull account to access the feature.
Biggest single-day increase in 52 years! International giant$3M (MMM.US)$The performance exceeded expectations, and the stock opened high and rose nearly 23%, with a 42.42% annual increase.
At the close, the company's stock soared 22.99% to $127.16, and the market cap rebounded to $69.86 billion. This is also the largest single-day increase in the company's stock price since record-keeping began in 1972.
The surge in 3M's stock price is related to its latest financial report. The latest report shows that 3M's net sales in the second quarter were $6.255 billion, a year-on-year decline of 0.5%, better than the analyst average expected $5.88 billion; adjusted sales of $6.019 billion, a year-on-year organic growth of 1.2%; earnings per share calculated according to GAAP were $2.17, a year-on-year increase of 117%; earnings per share after ongoing operations adjustments were $1.93, a year-on-year increase of 39%; adjusted operating income profit margin was 21.6%, a year-on-year increase of 4.4 percentage points.
Is private equity activity making a comeback?$KKR & Co (KKR.US)$Infrastructure Holdings, an education software platform, was acquired, and the stock price rose 1.54% to a new high; previously, Bain Capital announced the acquisition of PowerSchool Holdings.
US private equity giant KKR Group announced on Thursday that it will acquire Infrastructure Holdings, an education software platform, for $4.8 billion. Infrastructure provides learning management and educational technology solutions, supporting more than 200 million learners in more than 100 countries and regions. The company has more than 1,000 partners and aims to achieve revenue of $1 billion by 2028.
After a period of silence due to rising interest rates hindering debt financing for leveraged buyouts, this acquisition suggests that private equity activity may rebound. Prior to KKR's acquisition of Infrastructure, Bain Capital announced it would acquire PowerSchool Holdings for $5.6 billion.
Excellent performance and approval of new drugs brought double happiness!$AbbVie (ABBV.US)$Released better-than-expected second-quarter results. In addition, a new type 1 anti-AIDS drug was approved for clinical use in China. The stock price has risen by 22.87% this year. Other biotechnology companies have also performed well.$Thermo Fisher Scientific (TMO.US)$Up 2.13%, with an annual increase of 14.54%,$Danaher (DHR.US)$Up 1.41%, with an annual increase of 18.66%.
AbbVie announced second-quarter results with sales of $14.46 billion, exceeding expected $14.03 billion; adjusted earnings per share were $2.65, exceeding expected 8 cents. Sales of the popular anti-cancer drug Imbruvica fell by 8% to $833 million, still exceeding the expected $789 million.
On July 29, the Center for Drug Evaluation (CDE) of the China National Medical Products Administration website announced that AbbVie's class 1 new drug ABBV-382 injection was approved for clinical use in China. It aims to develop a drug that can continuously suppress the immune-mediated HIV (HIV plasma viral load is undetectable) without the use of combined antiretroviral therapy (ART). Public information shows that ABBV-382 is a monoclonal antibody against α4β7 integrin, which is in phase 2 clinical trials worldwide. This is the first time this candidate drug has been approved for clinical use in China.
$Mohawk Industries (MHK.US)$Exceeded expectations in the second quarter, surged more than 19% last Friday, and had the second highest increase in the S&P 500 constituent stocks for that day.
Bank of America Securities raised Mohawk Industries (MHK) from underperform to buy and raised its target price from $120 to $177. The company announced unexpected growth in the second quarter, and the guidance for the third quarter was higher than analysts' expectations. The stock price soared 19%, the second highest increase in the S&P 500 Index.
I. Innovative American stock giants
II. Innovative American individual stocks
III. Popular U.S. stock gains and losses rankings
Editor/Feynman